Impedimed Ltd - IPD share price
About
ImpediMed Limited, an Australian medical technology company, specializes in bioimpedance spectroscopy (BIS) systems for early detection of conditions like lymphoedema and heart failure. Their SOZO platform measures fluid status and tissue composition, aiding clinicians in managing chronic diseases. They offer devices like SFB7 for clinical and research use and ImpediVET for veterinary applications. SOZO applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Price Chart
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026
Latest Article